TBLB (n = 45) | TBLC (n = 25) | p value | |
---|---|---|---|
Male (n, %) | 28 (62.2) | 12 (48.0) | 0.249 |
Age, yrs (Median, IQR) | 59 (53.0–68.5) | 65 (50.5–68.5) | 0.654 |
CCI (Median, IQR) | 1.0 (0.0–2.0) | 1.0 (0.5–2.0) | 0.643 |
Immunocompromised host (n, %) | 10 (22.2) | 9 (36.0) | 0.214 |
Respiratory Support (n, %) | |||
HFNC | 31 (68.9) | 9 (36.0) | 0.008 |
NIPPV | 4 (8.9) | 1 (4.0) | 0.648 |
IPPV | 10 (22.2) | 6 (24.0) | 0.865 |
ECMO | 0 | 9 (36.0) | < 0.001 |
PFR, mmHg (Median, IQR) | 168 (104–220) | 130 (99–178) (n = 20) | 0.123 |
APACHE II score (Median, IQR) | 13.0 (11.0–19.5) | 20.0 (12.5–24.0) | 0.052 |
SOFA score (Median, IQR) | 4.0 (3.0–7.0) | 7.0 (3.0–10.0) | 0.040 |
PT, s (Median, IQR) | 14.5 (13.7–15.3) | 14.7 (13.9–16.1) | 0.249 |
APTT, s (Median, IQR) | 41.2 (36.5–45.4) | 42.0 (35.9–50.1) | 0.759 |
Platelet, *109/L (Median, IQR) | 249 (167–309) | 159 (97–256) | 0.027 |